A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants

NCT05431153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Single dose of PF-07104091 as Tablet Formulation A (Treatment A)
DRUG: Single dose of PF-07104091 as Tablet Formulation B (Treatment B)
DRUG: Single dose of PF-07104091 as Tablet Formulation C (Treatment C)
DRUG: Single dose of PF-07104091 as Tablet Formulation D (Treatment D)
DRUG: Single dose of PF-07104091 as Tablet Formulation C (Treatment E)

Sponsor

Pfizer